Satoshi Mori

6.1k total citations
143 papers, 4.2k citations indexed

About

Satoshi Mori is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, Satoshi Mori has authored 143 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Orthopedics and Sports Medicine, 50 papers in Oncology and 37 papers in Surgery. Recurrent topics in Satoshi Mori's work include Bone health and osteoporosis research (68 papers), Bone health and treatments (44 papers) and Bone Metabolism and Diseases (22 papers). Satoshi Mori is often cited by papers focused on Bone health and osteoporosis research (68 papers), Bone health and treatments (44 papers) and Bone Metabolism and Diseases (22 papers). Satoshi Mori collaborates with scholars based in Japan, United States and China. Satoshi Mori's co-authors include David B. Burr, Hiromichi Norimatsu, Tasuku Mashiba, W.S.S. Jee, Satoshi Komatsubara, Yoshio Kaji, S.T. Chan, Tomoyuki Akiyama, RC Harruff and Jun Kawanishi and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Brain Research.

In The Last Decade

Satoshi Mori

131 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Mori Japan	34	2.2k	1.3k	1.1k	1.1k	534	143	4.2k
Anil Mathur United States	29	2.1k 1.0×	687 0.5×	1.2k 1.1×	1.2k 1.1×	371 0.7×	84	6.0k
X. Sherry Liu United States	45	2.9k 1.4×	1.0k 0.8×	1.4k 1.2×	1.3k 1.3×	448 0.8×	99	5.3k
Maurice Audran France	33	1.9k 0.9×	1.2k 0.9×	1.1k 1.0×	641 0.6×	204 0.4×	163	3.8k
H. Oxlund Denmark	40	1.7k 0.8×	952 0.7×	1.2k 1.1×	1.2k 1.1×	733 1.4×	118	5.6k
N. Loveridge United Kingdom	40	2.8k 1.3×	1.1k 0.8×	1.9k 1.7×	1.6k 1.5×	432 0.8×	145	6.1k
Diane M. Cullen United States	28	1.5k 0.7×	489 0.4×	1.2k 1.0×	555 0.5×	357 0.7×	61	3.3k
Marie-Hélène Lafage–Proust France	44	2.2k 1.0×	876 0.7×	1.8k 1.5×	706 0.7×	448 0.8×	145	6.1k
Troels T. Andreassen Denmark	31	1.0k 0.5×	691 0.5×	966 0.8×	694 0.7×	591 1.1×	51	3.6k
Ali Ghasemzadeh Australia	29	2.0k 0.9×	762 0.6×	678 0.6×	858 0.8×	301 0.6×	73	3.1k
Hiroshi Kaji Japan	48	1.6k 0.7×	1.7k 1.3×	3.0k 2.6×	732 0.7×	872 1.6×	228	6.8k

Countries citing papers authored by Satoshi Mori

Since Specialization

Citations

This map shows the geographic impact of Satoshi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Mori more than expected).

Fields of papers citing papers by Satoshi Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Mori. The network helps show where Satoshi Mori may publish in the future.

Co-authorship network of co-authors of Satoshi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Mori. A scholar is included among the top collaborators of Satoshi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Mori. Satoshi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Shiro, et al.. (2025). Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05. Journal of Bone and Mineral Metabolism. 43(4). 448–457. 1 indexed citations

Takeuchi, Yasuhiro, Shiro Tanaka, Tatsuhiko Kuroda, et al.. (2024). Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05). Journal of Bone and Mineral Metabolism. 42(6). 675–680. 3 indexed citations

Ohta, Hiroaki, Yukari Uemura, Teruki Sone, et al.. (2023). Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene. Calcified Tissue International. 112(4). 430–439. 6 indexed citations

Taguchi, Akira, Shiro Tanaka, Satoshi Mori, et al.. (2023). Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05). Journal of Bone and Mineral Metabolism. 41(6). 854–864. 1 indexed citations

Hagino, Hiroshi, Yukari Uemura, Satoshi Mori, et al.. (2021). Risk factors for incident vertebral fractures in osteoporosis pharmacotherapy: a 2-year, prospective, observational study. Journal of Bone and Mineral Metabolism. 39(4). 668–677. 3 indexed citations

Hagino, Hiroshi, Toshitsugu Sugimoto, Shiro Tanaka, et al.. (2021). A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05. Osteoporosis International. 32(11). 2301–2311. 35 indexed citations

Hagino, Hiroshi, Naoto Endo, Tetsuji Yamamoto, et al.. (2017). Treatment status and radiographic features of patients with atypical femoral fractures. Journal of Orthopaedic Science. 23(2). 316–320. 7 indexed citations

Mori, Satoshi. (2016). [Bone quality and strength relating with bone remodeling].. PubMed. 26(1). 17–27. 2 indexed citations

Mori, Satoshi. (2014). [Justification criteria for vertebral fractures ; year 2012 revision].. PubMed. 24(3). 331–8. 1 indexed citations

10.

Mori, Satoshi. (2013). [SSBT (severely suppressed bone turnover) ].. PubMed. 23(3). 365–70. 2 indexed citations

11.

Mori, Satoshi. (2011). [Morphological analysis of bone dynamics and metabolic bone disease. Pathophisiology of Microdamage].. PubMed. 21(4). 559–65. 1 indexed citations

12.

Mori, Satoshi. (2009). [Bone fracture and the healing mechanisms. Microdamage and Microfracture].. PubMed. 19(5). 699–703. 3 indexed citations

13.

Mori, Satoshi. (2008). [Assessment of bone quality. Bone quality as the determinant of bone strength].. PubMed. 18(3). 293–9.

14.

Kamata, Hiroshi, et al.. (2007). Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin’s lymphomas. Clinical and Experimental Medicine. 7(2). 39–46. 10 indexed citations

15.

Mashiba, Tasuku, Satoshi Mori, Satoshi Komatsubara, et al.. (2005). THe effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. Journal of Bone and Mineral Metabolism. 23(S1). 36–42. 116 indexed citations

16.

Mori, Satoshi. (2004). [Contribution of bone quality to fracture risk].. PubMed. 14(10). 33–8. 5 indexed citations

17.

Fukuda, Kazuya, et al.. (1998). Middle-term results of anatomic medullary locking total hip arthroplasty. Archives of Orthopaedic and Trauma Surgery. 118(1-2). 14–20. 13 indexed citations

18.

Yoshikawa, Tomoaki, et al.. (1997). Bone Strength of Senescence Accelerated Mice. 7(1). 89–96. 1 indexed citations

19.

Sun, Ting, et al.. (1992). Do different fluorochrome labels give equivalent histomorphometric information?. Bone. 13(6). 443–446. 40 indexed citations

20.

Ohuchi, Noriaki, Satoshi Mori, M Akimoto, et al.. (1990). Clinical evaluation of CA72-4 immunoradiometric assay for serum TAG-72 antigen in patients with carcinoma. 5(1). 1–10. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact